Progyny Inc
PGNY
View Detailed Chart
18.650USD
-0.440-2.30%
Close 10/30, 16:00（ET）Quotes delayed by 15 min
1.60BMarket Cap
30.17P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-2.30%
5 Days
-4.36%
1 Month
-13.34%
6 Months
-18.35%
Year to Date
+8.12%
1 Year
+21.26%
View Detailed Chart
TradingKey Stock Score of Progyny Inc
Currency: USD Updated: 2025-10-30Key Insights
The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Progyny Inc's Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
10
analysts
Buy
Current Rating
28.714
Target Price
+50.42%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Progyny Inc Highlights
StrengthsRisks
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 48.33% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.17B.
Undervalued
The company’s latest PE is 30.14, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 89.73M shares, decreasing 22.89% quarter-over-quarter.
Held by Robert Olstein
Star Investor Robert Olstein holds 35.00K shares of this stock.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Progyny Inc Info
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Ticker SymbolPGNY
CompanyProgyny Inc
CEOMr. Peter (Pete) Anevski
Websitehttps://www.progyny.com/
Related Instruments
Popular Symbols
